Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Altimmune (ALT) Leases (2019 - 2025)

Altimmune (ALT) has disclosed Leases for 7 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • Quarterly Leases fell 13.06% to $1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, down 13.06% year-over-year, with the annual reading at $1.4 million for FY2025, 13.06% down from the prior year.
  • Leases for Q4 2025 was $1.4 million at Altimmune, down from $1.6 million in the prior quarter.
  • The five-year high for Leases was $1.7 million in Q2 2024, with the low at $300000.0 in Q1 2024.
  • Average Leases over 5 years is $855519.5, with a median of $750000.0 recorded in 2022.
  • Peak annual rise in Leases hit 351.52% in 2024, while the deepest fall reached 44.55% in 2024.
  • Over 5 years, Leases stood at $798000.0 in 2021, then dropped by 25.31% to $596000.0 in 2022, then tumbled by 39.09% to $363000.0 in 2023, then surged by 351.52% to $1.6 million in 2024, then dropped by 13.06% to $1.4 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $1.4 million, $1.6 million, and $1.7 million for Q4 2025, Q4 2024, and Q3 2024 respectively.